Search results
Jun 27, 2024 · has secured long-term power purchase agreements (PPAs) with subsidiaries of global biopharma company GSK. According to a June 27 bourse filing, the subsidiary — Sembcorp Power — will supply up to 10 megawatts (MW) of electricity to all three of GSK’s global manufacturing sites in Singapore.
3 days ago · SINGAPORE — US pharmaceutical giant Pfizer opened its new $1 billion plant in Singapore on Tuesday ... Britian's GSK in July 2023 broke ground of its $343 million vaccines facility at Tuas.
Jun 28, 2024 · Sembcorp Industries subsidiary Sembcorp Power Corp. has secured long-term power purchase agreements to supply up to 10 megawatts of electricity to all three of GSK’s manufacturing sites in Singapore.
Jun 28, 2024 · Global pharmaceutical giant GSK has announced a transformative step towards sustainability by entering into a decade-long agreement with Sembcorp Industries. This partnership will supply renewable electricity to all three of GSK’s manufacturing facilities in Singapore starting January 1, 2025.
- Pooja Chandak
6 days ago · Under the partnership, Zuellig Pharma Singapore will provide GSK with warehousing and distribution services in cold-chain management for its vaccines. The vaccine hub will also leverage Zuellig Pharma's expertise in blockchain technology for China, one of GSK's largest APAC markets.
Jul 3, 2024 · GSK has signed a 10-year energy deal with Sembcorp in Singapore. This agreement will commence in January 2025, and all three of GSK’s global manufacturing sites in Singapore will be powered entirely by renewable electricity.
Jul 15, 2024 · Singapore’s Sembcorp Industries Ltd is set to supply up to 10 MW of power and renewable energy certificates (RECs) from its solar projects to global biopharma group GSK Plc for its operations in the Southeast Asian city-state.
